(Reuters) - "There are some pieces of Boston Scientific we've acquired or inherited over the years that are no longer strategic," said Lawrence Best, executive vice president and chief financial officer.
"It's better to simplify our business and basically liquidate our positions, or divest from those businesses," said Best, who is due to retire from his position in July. "This is a good thing. This will help fund some of the debt repayment. It also simplifies the business and allows management to focus on the sweet spots."
Read more at Reuters.com Business News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment